Magnetic resonance molecular imaging of the HER-2/neu receptor

Cancer Research

Volumn 63, Issue 11, 2003, Pages 2723-2727

  Artemov, Dmitri ^a   Mori, Noriko ^a   Ravi, Rajani ^a   Bhujwalla, Zaver M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GADOLINIUM PENTETATE; MONOCLONAL ANTIBODY; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; CANCER IMMUNOTHERAPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; MOUSE; MULTIPLE CANCER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS;

ANIMALS; AVIDIN; CONTRAST MEDIA; FEMALE; FLOW CYTOMETRY; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, SCID; MICE, TRANSGENIC; RATS; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED;

EID: 0038277090     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Louie, A. Y., Huber, M. M., Ahrens, E. T., Rothbacher, U., Moats, R., Jacobs, R. E., Fraser, S. E., and Meade, T. J. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol., 18: 321-325, 2000.
2. Dodd, S. J., Williams, M., Suhan, J. P., Williams, D. S., Koretsky, A. P., and Ho, C. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys. J., 76: 103-109, 1999.
3. Weissleder, R., Cheng, H. C., Bogdanova, A., and Bogdanov, A. Magnetically labeled cells can be detected by MR imaging. J. Magn. Reson. Imaging, 7: 258-263, 1997.
4. Moore, A., Basilion, J. P., Chiocca, E. A., and Weissleder, R. Measuring transferrin receptor gene expression by NMR imaging. Biochim. Biophys. Acta, 1402: 239-249, 1998.
5. Bulte, J. W., Zhang, S., van Gelderen, P., Herynek, V., Jordan, E. K., Duncan, I. D., and Frank, J. A. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl. Acad. Sci. USA, 96: 15256-15261, 1999.
6. Gohr-Rosenthal, S., Schmitt-Willich, H., Ebert, W., and Conrad, J. The demonstration of human tumors on nude mice using gadolinium-labelled monoclonal antibodies for magnetic resonance imaging. Investig. Radiol., 28: 789-795, 1993.
7. Sato, N., Kobayashi, H., Hiraga, A., Saga, T., Togashi, K., Konishi, J., and Brechbiel, M. W. Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores. Magn. Reson. Med., 46: 1169-1173, 2001.
8. 3-targeted magnetic resonance imaging. Nat. Med., 4: 623-626, 1998.
9. DeGiovanna, M. Clinical Significance of HER-2/neu Overexpression. Philadelphia: Lippincott Williams & Wilkins, 1999.
10. Kim, Y. S., Konoplev, S. N., Montemurro, F., Hoy, E., Smith, T. L., Rondon, G., Champlin, R. E., Sahin, A. A., and Ueno, N. T. HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation. Clin. Cancer Res., 7: 4008-4012, 2001.
11. Wang, S. C., Zhang, L., Hortobagyi, G. N., and Hung, M. C. Targeting HER2: recent developments and future directions for breast cancer patients. Semin. Oncol., 28: 21-29, 2001.
12. Hortobagyi, G. N. Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer. Semin. Oncol., 28: 43-47, 2001.
13. Reilly, R. T., Gottlieb, M. B., Ercolini, A. M., Machiels, J. P., Kane, C. E., Okoye, F. I., Muller, W. J., Dixon, K. H., and Jaffee, E. M. HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice. Cancer Res., 60: 3569-3576, 2000.
14. Hnatowich, D. J., Virzi, F., and Rusckowski, M. Investigations of avidin and biotin for imaging applications. J. Nucl. Med., 28: 1294-1302, 1987.
15. Bhujwalla, Z. M., Artemov, D., Natarajan, K., Ackerstaff, E., and Solaiyappan, M. Vascular diffrences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia, 3: 1-11, 2000.
16. Venter, D. J., Tuzi, N. L., Kumar, S., and Gullick, W. J. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet, 2: 69-72, 1987.
17. Schechter, B., Silberman, R., Arnon, R., and Wilchek, M. Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin. Eur. J. Biochem., 189: 327-331, 1990.
18. Pegram, M. D., Lipton, A., Hayes, D. F., Weber, B. L., Baselga, J. M., Tripathy, D., Baly, D., Baughman, S. A., Twaddell, T., Glaspy, J. A., and Slamon, D. J. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-over-expressing metastatic breast cancer refractory to chemotherapy treatment. J. Clin. Oncol., 16: 2659-2671, 1998.
19. Paganelli, G., Bartolomei, M., Ferrari, M., Cremonesi, M., Broggi, G., Maira, G., Sturiale, C., Grana, C., Prisco, G., Gatti, M., Caliceti, P., and Chinol, M. Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: Phase I study and preliminary therapeutic results. Cancer Biother. Radiopharm., 16: 227-235, 2001.
20. Paganelli, G., Grana, C., Chinol, M., Cremonesi, M., De Cicco, C., De Braud, F., Robertson, C., Zurrida, S., Casadio, C., Zoboli, S., Siccardi, A. G., and Veronesi, U. Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur. J. Nucl. Med., 26: 348-357, 1999.
21. Cremonesi, M., Ferrari, M., Chinol, M., Stabin, M. G., Grana, C., Prisco, G., Robertson, C., Tosi, G., and Paganelli, G. Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients. Eur. J. Nucl. Med., 26: 110-120, 1999.
22. Behra-Miellet, J. G. B., Brunet, C., Dine, T., Luyckx, M., Cazin, M., and Cazin, J. C. Free gadolinium and gadodiamide, a gadolinium chelate used in magnetic resonance imaging: evaluation of their in vitro effects on human neutrophil viability. Methods Find Exp. Clin. Pharmacol., 18: 437-442, 1996.
23. Kobayashi, H., Sato, N., Hiraga, A., Saga, T., Nakamoto, Y., Ueda, H., Konishi, J., Togashi, K., and Brechbiel, M. W. 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties. Magn. Reson. Med., 45: 454-460, 2001.
24. Spencer, A. W. S., and Harpur, E. Gadolinium chloride toxicity in the mouse. Hum. Exp. Toxicol., 17: 633-637, 1998.
25. Spencer, A. J. W. S., Batchelor, J., Reid, A., Rees, J., and Harpur, E. Gadolinium chloride toxicity in the rat. Toxicol. Pathol., 25: 245-255, 1997.